Literature DB >> 26043676

Expression of BMI1 and ZEB1 in epithelial-mesenchymal transition of tongue squamous cell carcinoma.

Kinue Kurihara1, Tomohide Isobe2, Gou Yamamoto2, Yoichi Tanaka3, Akira Katakura1, Tetsuhiko Tachikawa4.   

Abstract

Epithelial-mesenchymal transition (EMT) is a crucial event required for the invasion and progression of carcinogenesis, inducing stem-like properties in epithelial cells. In the present study, the expression of BMI1, which controls self-renewal in stem cells, as well as that of ZEB1, a transcription factor that regulates EMT, was evaluated for its role in EMT and the carcinogenic processes of tongue squamous cell carcinoma (TSCC). Collagen invasion assays using two TSCC cells and 64 tongue specimens (32 carcinomas and 32 dysplasias) were employed and analyzed in the present study. We assessed the protein and mRNA expression levels of BMI1, ZEB1, vimentin and E-cadherin in the two cell lines and tumor tissues. The protein and mRNA expression of BMI1 and ZEB1 occurred at the invasion of TSCC. The elevated levels of BMI1 and ZEB1 were accompanied by the downregulation of E-cadherin and upregulation of vimentin at the invasive front, indicative of EMT in vitro and in vivo. The results showed that BMI1 and ZEB1 are important factors in association with the promotion of EMT and invasion of TSCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26043676     DOI: 10.3892/or.2015.4032

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 2.  TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Authors:  Hong Ren; Peizhun Du; Zongyu Ge; Yiting Jin; Di Ding; Xiuping Liu; Qiang Zou
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

3.  Marked epithelial to mesenchymal transition in surgical margins of oral cancer-an in vitro study.

Authors:  Milos Lazarevic; Maja Milosevic; Drago Jelovac; Sanja Milenkovic; Zvezdana Tepavcevic; Federica Baldan; Tijana Suboticki; Bosko Toljic; Dijana Trisic; Miroslav Dragovic; Giuseppe Damante; Jelena Milasin
Journal:  Oncol Lett       Date:  2020-03-29       Impact factor: 2.967

4.  Decreased Sox2 Messenger RNA Expression in Basal Cell Carcinoma.

Authors:  Reza Ahmadi-Beni; Fatemeh Vand-Rajabpour; Mohamadreza Ahmadifard; Maryam Daneshpazhooh; Pedram Noormohammadpour; Javad Rahmati; Kambiz Kamyab Hesari; Mehdi Yaseri; Mina Tabrizi
Journal:  Indian J Dermatol       Date:  2020 May-Jun       Impact factor: 1.494

5.  Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.

Authors:  Jin Young Kim; Kyung Hwa Cho; Bo Young Jeong; Chang Gyo Park; Hoi Young Lee
Journal:  Exp Mol Med       Date:  2020-07-30       Impact factor: 8.718

6.  The immunophenotype of epithelial to mesenchymal transition inducing transcription factors in salivary gland adenoid cystic carcinomas.

Authors:  Iulia Cristiana Belulescu; Claudiu Mărgăritescu; Cristiana Iulia Dumitrescu; Maria Cristina Munteanu; Luminiţa Dăguci; Otilia Clara Mărgăritescu; Marius Matei
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

7.  High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma.

Authors:  Takuya Komiyama; Takeshi Kuroshima; Takehito Sugasawa; Shin-Ichiro Fujita; Yuta Ikami; Hideaki Hirai; Fumihiko Tsushima; Yasuyuki Michi; Kou Kayamori; Fumihiro Higashino; Hiroyuki Harada
Journal:  Oncol Rep       Date:  2022-09-09       Impact factor: 4.136

Review 8.  Oral Cancer Stem Cells: Therapeutic Implications and Challenges.

Authors:  Linah A Shahoumi
Journal:  Front Oral Health       Date:  2021-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.